Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Camurus Ab

Clinical trials sponsored by Camurus Ab, explained in plain language.

Camurus AB CAMX NASDAQ STOCKHOLM

Swedish pharmaceutical company developing long-acting drug delivery products.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 2 Completed 1

New study tracks Octreotide's Real-World impact on acromegaly over two years

Disease control Recruiting now

This study follows 200 people with acromegaly who are using octreotide subcutaneous depot, a medication that helps control hormone levels. Researchers will monitor safety and effectiveness for up to two years in everyday clinical practice, not a controlled lab setting. The goal i…

Sponsor: Camurus AB • Aim: Disease control

Last updated Aug 14, 2026 00:00 UTC